News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
December, 2024
December 2024
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
3031  
TREM2+ Multinucleated Giant Macrophages as a Prognostic Marker in Head and Neck Squamous Cell Carcinoma
Cancer Discovery/X
Dec 19, 2024, 14:34

TREM2+ Multinucleated Giant Macrophages as a Prognostic Marker in Head and Neck Squamous Cell Carcinoma

Cancer Discovery shared a post on X:

“From the December issue:

TREM2–expressing Multinucleated Giant Macrophages Are a Biomarker of Good Prognosis in Head and Neck Squamous Cell Carcinoma – by Gessain Grégoire, Florent Ginhoux and colleagues.

Authors: Grégoire Gessain, Ahmed-Amine Anzali, Marvin Lerousseau, Kevin Mulder, Mathilde Bied, Anne Auperin, Daniel Stockholm, Nicolas Signolle, Farah Sassi, Maria Eugenia Marques Da Costa, Antonin Marchais, Alexandre Sayadi, Daniela Weidner, Stefan Uderhardt, Quentin Blampey, Sumanth Reddy Nakkireddy, Sophie Broutin, Charles-Antoine Dutertre, Pierre Busson, Thomas Walter, Alix Marhic, Antoine Moya-Plana, Johanne Guerlain, Ingrid Breuskin, Odile Casiraghi, Philippe Gorphe, Marion Classe, Jean-Yves Scoazec, Camille Blériot, Florent Ginhoux.”

TREM2+ Multinucleated Giant Macrophages as a Prognostic Marker in Head and Neck Squamous Cell Carcinoma

Ahmed-Amine Anzali Alexandre Sayadi Alix Marhic Anne Auperin Antoine Moya-Plana Antonin Marchais biomarker Camille Blériot cancer Cancer Discovery Charles-Antoine Dutertre Daniel Stockholm Daniela Weidner Farah Sassi Florent Ginhoux Grégoire Gessain Ingrid Breuskin Jean-Yves Scoazec Johanne Guerlain Kevin Mulder Maria Eugenia Marques Da Costa Marion Classe Marvin Lerousseau Mathilde Bied Nicolas Signolle Odile Casiraghi oncology oncodaily Philippe Gorphe Pierre Busson Quentin Blampey Sophie Broutin squamous cell carcinoma Stefan Uderhardt Sumanth Reddy Nakkireddy Thomas Walter TREM2
Special Coverage
Insight
Dec 19, 2024, 14:34
TREM2+ Multinucleated Giant Macrophages as a Prognostic Marker in Head and Neck Squamous Cell Carcinoma
Blog
Dec 19, 2024, 14:31
Vote on the proposed IASLC ByLaw changes
Blog
Dec 19, 2024, 14:28
Cardiovascular Risks in Breast Cancer Survivors
Blog
Dec 19, 2024, 14:26
Chokri Ben Lamine: Common Hematology Drugs - 'With or Without Food' Guidance
Blog
Dec 19, 2024, 14:18
ACSBCN - Learning about the latest advancements in breast cancer research in SABCS
Career
Dec 19, 2024, 14:11
The Community Oncology Alliance Welcomed Debra Patt as New President
Blog
Dec 19, 2024, 14:08
Durable Objective Response to Lurbinectedin in Small Cell Bladder Cancer with TP53 Mutation
Blog
Dec 19, 2024, 14:04
Patrick Hwu: Celebrating the year and Moffitt Cancer Center's all accomplishments
Blog
Dec 19, 2024, 14:01
The ESMO Asia Congress 2024 was a milestone in advancing oncology research and treatment in Asia-Pacific
Blog
Dec 19, 2024, 13:55
Efficacy of Subsequent Treatments After Disease Progression on CDK4/6 Inhibitors in Hormone Receptor–Positive Breast cancer
Insight
Dec 19, 2024, 13:48
Myeloma Paper of the Day, December 19th, suggested by Robert Orlowski
Blog
Dec 19, 2024, 13:35
OncoInfluencers to Follow on Social Media: Catharine Young